First-line treatment of hymenoptera venom anaphylaxis: a 23-year real-life experience

Anaphylaxis represents a significant health care burden and occurs in approximately 1% to 3% of people annually.1,2 Allergy to hymenoptera venom occurs in 0.15% to 0.8% of children and 0.3% to 8.9% of adults.3 The complex management of anaphylaxis consists of emergency treatment of acute episodes, follow-up procedures including the prescription of epinephrine, and referral to an allergist. Therefore, it was of interest to investigate the medical care given to patients with systemic reactions after hymenoptera insect stings in Silesia, a southern region of Poland.

http://ift.tt/2jCUWjE